Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Retrophin Inc (NASDAQ:RTRX)

22.04
Delayed Data
As of Dec 13
 +1.00 / +4.75%
Today’s Change
15.55
Today|||52-Week Range
26.44
+16.43%
Year-to-Date
No recent news for Retrophin Inc.

Today’s Trading

Previous close21.04
Today’s open21.07
Day’s range21.07 - 22.19
Volume363,105
Average volume (3 months)279,475
Market cap$807.6M
Data as of 4:00pm ET, 12/13/2017

Growth & Valuation

Earnings growth (last year)-140.69%
Earnings growth (this year)+3.29%
Earnings growth (next 5 years)+137.00%
Revenue growth (last year)+33.74%
P/E ratioNM
Price/Sales5.43
Price/Book2.59

Competitors

 Today’s
change
Today’s
% change
FPRXFive Prime Therapeut...-0.13-0.59%
EDITEditas Medicine Inc+0.79+3.35%
EPZMEpizyme Inc+0.60+4.74%
----
Data as of 4:00pm ET, 12/13/2017

Financials

Next reporting dateMarch 29, 2018
EPS forecast (this quarter)-$0.18
Annual revenue (last year)$133.6M
Annual profit (last year)-$47.9M
Net profit margin-35.86%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Stephen J. Aselage
Chief Operating Officer
Neil McFarlane
Corporate headquarters
San Diego, California

Forecasts